...
首页> 外文期刊>Journal of Liquid Chromatography & Related Technologies >RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ATORVASTATIN CALCIUM, LOSARTAN POTASSIUM, ATENOLOL, AND ASPIRIN FROM TABLET DOSAGE FORM AND PLASMA
【24h】

RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ATORVASTATIN CALCIUM, LOSARTAN POTASSIUM, ATENOLOL, AND ASPIRIN FROM TABLET DOSAGE FORM AND PLASMA

机译:RP-HPLC法同时从片剂剂量形式和血浆中估算阿托伐他汀钙,洛沙坦钾,阿替洛尔和阿司匹林

获取原文
获取原文并翻译 | 示例

摘要

A rapid, simple, sensitive, and selective chromatographic method has been developed for the simultaneous estimation of atorvastatin calcium, losartan potassium, atenolol, and aspirin in marketed formulation. The separation was carried out on a KYA TECH HiQ Sil C18HS (250 × 4.6 mm i.d., 5 µm particle size) column using a mobile phase of acetonitrile: 0.02 M potassium dihydrogen phosphate buffer (pH 3.4) (70:30% v/v). The chromatographic analysis has been carried out using flow rate of 1 mL/min and detection at 236 nm. The proposed method was applied for analysis of ATN, ASP, LOS and ATO from plasma. ATO showed a linear response in the concentration range of 4-24 µg/mL, LOS and ATN showed a linear response in the concentration range of 20-120 µg/mL and ASP showed a linear response in the concentration range of 30-180 µg/mL in tablet formulation analysis. ATO, LOS, ASP, and ATN showed a linear response in the concentration range of 25-150, 50-300, 100-600, and 50-300 ng/mL in plasma analysis, respectively. The proposed methods for analysis of the four drugs from marketed formulation and plasma have been validated as per ICH and USFDA guidelines, respectively. Thus, proposed methods have their applications in field of bioequivalence and pharmacokinetic studies.View full textDownload full textKeywordsaspirin, atenolol, atorvastatin calcium, losartan potassium, plasma, RP-HPLCRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; Add to shortlist Link Permalink http://dx.doi.org/10.1080/10826076.2011.601495
机译:已开发出一种快速,简单,灵敏和选择性的色谱方法,用于同时估算市售制剂中的阿托伐他汀钙,氯沙坦钾,阿替洛尔和阿司匹林。使用乙腈流动相在KYA TECH HiQ Sil C18HS(250×4.6 mm内径,5 µm粒径)色谱柱上进行分离:0.02 M磷酸二氢钾缓冲液(pH 3.4)(70:30 %v / v)。使用1 mL / min的流速和在236 nm的检测进行了色谱分析。该方法用于血浆中ATN,ASP,LOS和ATO的分析。 ATO在4-24 µg / mL的浓度范围内显示线性响应,LOS和ATN在20-120 µg / mL的浓度范围内显示线性响应,ASP在30-180 µg的浓度范围内显示线性响应/ mL在片剂配方分析中。 ATO,LOS,ASP和ATN在血浆分析中分别在25-150、50-300、100-600和50-300 ng / mL的浓度范围内显示线性响应。从市售制剂和血浆中分析四种药物的建议方法已分别按照ICH和USFDA指南进行了验证。因此,所提出的方法在生物等效性和药代动力学研究领域中具有应用。查看全文下载全文citeulike,netvibes,twitter,technorati,美味,linkedin,facebook,stumbleupon,digg,google,更多”,发布:“ ra-4dff56cd6bb1830b”};添加到候选列表链接永久链接http://dx.doi.org/10.1080/10826076.2011.601495

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号